Clinical presentation of hospitalized adult patients with HIV infection and AIDS in Bangkok, Thailand

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 4, 1999, Pages 326-332

  Tansuphasawadikul, Somsit ^a   Amornkul, Pauli N ^b,e   Tanchanpong, Chana ^a   Limpakarnjanarat, Khanchit ^c,f   Kaewkungwal, Jaranit ^c,d   Likanonsakul, Sirirat ^a   Eampokalap, Boonchuey ^a   Naiwatanakul, Thananda ^c   Kitayaporn, Dwip ^c,d   Young, Nancy L ^b,c   Hu, Dale J ^b   Mastro, Timothy D ^b,c  

^a Bamrasnaradura Infectious Disease Institute   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HIV/AIDS Collaboration   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

AIDS; Asia; Clinical spectrum; Cryptococcosis; Injection drug users; Sexual transmission; Thailand; Tuberculosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CRYPTOCOCCOSIS; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PREVALENCE; PRIORITY JOURNAL; THAILAND; TUBERCULOSIS; WASTING SYNDROME;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PNEUMOCYSTIS CARINII;

EID: 0033179087     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-199908010-00011     Document Type: Article

References (35)

1. UNAIDS/WHO. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS/WHO, 1998.
2. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 91;5:S71-85.
3. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand [published erratum appears in Lancet 1993;24;342:250]. Lancet 1993;341:1171-4.
4. Subbarao S, Limpakarnjanarat K, Mastro TD, et al. HIV-1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity. AIDS Res Hum Retroviruses 1998;14:319-27.
5. Mastro TD, Limpakarnjanarat K. Condom use in Thailand: how much is it slowing the HIV/AIDS epidemic? AIDS 1995;9:523-35.
6. Thai Ministry of Public Health. HIV/AIDS situation in Thailand. Update: December 1994. Bangkok: Thai Ministry of Public Health, 1995.
7. National Economic and Social Development Board Working Group. Projections for HIV in Thailand, 1987-2005. An Application of EPIMODEL. Bangkok: National Economic and Social Development Board Working Group, 1994.
8. Kitayaporn D, Tansuphaswadikul S, Lohsomboon P, et al. Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. J Acquir Immun Defic Syndr Hum Retrovirol 1996;11:77-82.
9. Ittiravivongs A, Likanonsakul S, Mastro TD, et al. Evaluation of a confirmatory HIV testing strategy in Thailand not using Western blot. J Acquir Immune Defic Syndr 1996;13:296-7.
10. Thai surveillance case definition for AIDS and HIV infection [in Thai]. Weekly Epidemiol Surveill Rep 1993;24(Suppl):1-39.
11. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;41:1-23.
12. Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg 96;55:1-11.
13. Thongcharoen P, Vithayasai P, Vithayasai V, Supparatpinyo K, Tansuphaswadikul S. Opportunistic infections in AIDS/HIV infected patients in Thailand. Thai AIDS J 1992;4:117-22.
14. Swasdisevi A. Clinical study of HIV disease in the lower area of northern Thailand in 1994. J Med Assoc Thai 94;77:440-3.
15. Jones JL, Hanson DL, Chu SY, Fleming PL, Hu DJ, Ward JW. Surveillance of AIDS-defining conditions in the United States. Adult/Adolescent Spectrum of HIV Disease Project Group. AIDS 94;8:1489-93.
16. Hu DJ, Fleming PL, Castro KG, et al. How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions? J Acquir Immun Defic Syndr Hum Retrovirol 1995;10:374-80.
17. Wongwatana S, Sriyabhaya N. Nontuberculous Mycobacterial infection of the lung in a chest hospital in Thailand. J Med Assoc Thai 92;75:1-10.
18. Yanai H, Uthaivoravit W, Panich V, et al. Rapid increase in HIV-related tuberculosis, Chiang Rai, Thailand, 1990-1994. AIDS 96;10:527-31.
19. Akarasewi P, Rawungpan N, Prapanwong A, Natpratan C, Sriyabhaya N. Rising trend of registered TB cases in higher prevalence area of HIV infection in Northern Thailand. Tuber Lung Dis 94;75(Suppl 1):S6.
20. Chuchottaworn C, Buranajaru B, Likanonskul S, Panyatungsakul P. Prevalence of HIV infection in Thai TB patient [in Thai]. Thai J Tuberc Chest Disease 89;10:149-56.
21. Wiriyakitjar D, Rattanadilik N, Bhuket T, Rienthong D, Kowathana K. Surveillance of HIV infection among TB patients in Bangkok Chest Clinic [in Thai]. Thai AIDS J 92;4:14-9.
22. Punnotok J, Pumpug U, Naiwatanakul T, et al. HIV infection and TB associated with injecting drug use and resistant M. tuberculosis, Bangkok, Thailand [abstract]. Presented at the XII World AIDS Conference, Geneva, Switzerland, 1998.
23. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72.
24. DeCock KM, Grant AD, Porter JD. Preventive therapy for tuberculosis in HIV-infected persons: international recommendations, research, and practice. Lancet 95;345:833-6.
25. DeCock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 92;268:1581-7.
26. Powderly WG, Finkelstein D, Feinberg J, et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 95;332:700-5.
27. Deng Z, Ribas JL, Gibson DW, Connor E. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 88:10:640-52.
28. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 94;344:110-3.
29. Imwidthaya P. Update on Penicillosis marneffei in Thailand. Mycopathologia 94;127:135-7.
30. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Praparattanapan J, Nelson KE. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand. Clin Infect Dis 97;24: 1080-6.
31. Gilks CF, Brindle RJ, Otieno LS, et al. Life-threatening, bacteremia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 90;336:545-9.
32. Vugia DJ, Kiehlbauch JA, Yeboue KM, et al. Pathogens and predictors of fatal septicimia associated with human immunodeficiency virus infection in Ivory Coast, west Africa. J Infect Dis 93;168:564-70.
33. Volberding PA, Lagakos SW, Koch MA, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med 90;322:941-9.
34. Cooper DA, Gatell JM, Kroon S, et al. Zidovudine in persons with asymptomatic HIV infection and CD4-T cell counts greater than 400 per cubic millimeter. N Engl J Med 93;329:297-303.
35. Graham NMH, Zeger SL, Park LP, et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 92;326:1037-42.